Share

December 2015; 2 (6) ArticleOpen Access

Antibodies to MOG in adults with inflammatory demyelinating disease of the CNS

Sung-Min Kim, Mark R. Woodhall, Ji-Sun Kim, Seong-Joon Kim, Kyung Seok Park, Angela Vincent, Kwang-Woo Lee, Patrick Waters
First published October 15, 2015, DOI: https://doi.org/10.1212/NXI.0000000000000163
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
3302

Share

Article Information

vol. 2 no. 6 e163
DOI: 
https://doi.org/10.1212/NXI.0000000000000163
PubMed: 
26516628
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Online ISSN: 
2332-7812
History: 
  • Received June 22, 2015
  • Accepted in final form August 21, 2015
  • First Published October 15, 2015.
Copyright & Usage: 
© 2015 American Academy of Neurology This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0 (CC BY-NC-ND), which permits downloading and sharing the work provided it is properly cited. The work cannot be changed in any way or used commercially.

Author Disclosures

    1. Sung-Min Kim, MD, PhD*,
    2. Mark R. Woodhall, PhD,
    3. Ji-Sun Kim, MD,
    4. Seong-Joon Kim, MD, PhD,
    5. Kyung Seok Park, MD, PhD,
    6. Angela Vincent, FRS,
    7. Kwang-Woo Lee, MD, PhD and
    8. Patrick Waters, PhD*
  1. Sung-Min Kim, MD, PhD*,
    2. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. grant no. A121118 from the Korea Health Industry Development Institute Research fund

    Research Support, Academic Entities:

    1. 03-2015-1284 SNUH Research Fund.

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Mark R. Woodhall, PhD,
    3. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  3. Ji-Sun Kim, MD,
    4. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  4. Seong-Joon Kim, MD, PhD,
    5. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  5. Kyung Seok Park, MD, PhD,
    6. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  6. Angela Vincent, FRS,
    7. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. None in last two years

    Editorial Boards:

    1. Advisory Editorial Board Neurology 2014 - Associate Editor for Brain ended 2013

    Patents:

    1. Hold patent with Oxford University for LGI1/CASPR2 antibodies, licensed to Euroimmun AG, and for GABAAR antibodies, in negotiation with Euroimmun AG.

    Publishing Royalties:

    1. Royalties from Athena Diagnostics (MuSK assays). Royalties received from Euroimmun AG (LGI1 and CASPR2 assays) Clinical Neuroimmunology (Blackwell Publishing, 2005) and Inflammatory and Autoimmune Disorders of the Nervous System in Children (Mac Keith Press 2010).

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. Consultancy with Athena Diagnostics for assessing their antibody assays ?5K pa. Ended 2014.

    Speakers' Bureaus:

    1. Scientific conference expenses only

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NIHR general support for antibody work

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  7. Kwang-Woo Lee, MD, PhD and
    8. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  8. Patrick Waters, PhD*
    9. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. Speaker honoraria from Biogen Idec Japan and Euroimmun AG.

    Editorial Boards:

    1. Frontiers in molecular innate immunity, Review editor

    Patents:

    1. Assays for the detection of antibodies to lgi1, Caspr2, Tag-1 and GABAAR.

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. Patents for CASPR2, LGI1, TAG-1 and GABAAR.

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. From the Department of Neurology (S.-M.K., J.-S.K., K.S.P., K.-W.L.) and Ophthalmology (S.-J.K.), Seoul National University College of Medicine, Seoul, Republic of Korea; Nuffield Department of Clinical Neurosciences (M.R.W., A.V., P.W.), John Radcliffe Hospital, Oxford, United Kingdom; and Department of Neurology (K.S.P.), Seoul National University Bundang Hospital, Gyeonggi, Republic of Korea.
  1. Correspondence to Dr. Sung-Min Kim: sueh916{at}gmail.com or Dr. Waters: paddy.waters{at}ndcn.ox.ac.uk

Article usage

Article usage: October 2015 to October 2023

AbstractFullPdfSource
Oct 201525723749Highwire
Oct 2015020pmc
Nov 201528118198Highwire
Nov 20150220184pmc
Dec 2015637206152Highwire
Dec 201509682pmc
Jan 201625315847Highwire
Jan 201608253pmc
Feb 20161163732Highwire
Feb 201607960pmc
Mar 2016812010Highwire
Mar 201607275pmc
Apr 2016582210Highwire
Apr 201608638pmc
May 2016582514Highwire
May 201608761pmc
Jun 2016381416Highwire
Jun 201604531pmc
Jul 2016492215Highwire
Jul 201605025pmc
Aug 2016501913Highwire
Aug 201603021pmc
Sep 201639106Highwire
Sep 201602919pmc
Oct 2016411420Highwire
Oct 201605433pmc
Nov 2016272117Highwire
Nov 201604021pmc
Dec 2016301111Highwire
Dec 201602620pmc
Jan 201741199Highwire
Jan 201703213pmc
Feb 201734183Highwire
Feb 201705319pmc
Mar 201726217Highwire
Mar 201704314pmc
Apr 201724227Highwire
Apr 2017134143pmc
May 2017222212Highwire
May 2017225860pmc
Jun 201712126Highwire
Jun 2017164754pmc
Jul 201711699Highwire
Jul 2017204153pmc
Aug 2017191911Highwire
Aug 2017173843pmc
Sep 201718237Highwire
Sep 2017184553pmc
Oct 2017202511Highwire
Oct 2017165354pmc
Nov 201733269Highwire
Nov 2017267383pmc
Dec 20173635Highwire
Jan 201865314Highwire
Feb 201856710Highwire
Mar 201847816Highwire
Apr 20183823Highwire
Apr 2018208286pmc
May 2018412624Highwire
Jun 2018215124Highwire
Jun 2018145152pmc
Jul 2018322019Highwire
Aug 2018920631Highwire
Aug 2018214444pmc
Sep 2018413017Highwire
Oct 2018916634Highwire
Nov 2018815614Highwire
Dec 2018723015Highwire
Jan 2019523012Highwire
Feb 201932219Highwire
Mar 201999912Highwire
Apr 201976618Highwire
May 2019158420Highwire
Jun 2019610419Highwire
Jul 20191312628Highwire
Aug 20191312440Highwire
Sep 2019910918Highwire
Oct 201977019Highwire
Nov 201995622Highwire
Dec 2019810527Highwire
Jan 202067319Highwire
Feb 202036413Highwire
Mar 202088430Highwire
Apr 202075235Highwire
May 202049531Highwire
Jun 202026811Highwire
Jul 202035620Highwire
Aug 202056821Highwire
Sep 20201217721Highwire
Oct 2020813921Highwire
Nov 202066719Highwire
Dec 2020107121Highwire
Jan 202177120Highwire
Feb 202144611Highwire
Mar 2021137531Highwire
Apr 202188222Highwire
May 2021109421Highwire
Jun 202186519Highwire
Jul 202185117Highwire
Aug 202157326Highwire
Sep 202144710Highwire
Oct 202137537Highwire
Nov 202114918Highwire
Dec 2021139618Highwire
Jan 2022116916Highwire
Feb 20223428Highwire
Mar 202287015Highwire
Apr 2022410313Highwire
May 2022116116Highwire
Jun 202255017Highwire
Jul 2022415917Highwire
Aug 2022823011Highwire
Sep 2022415617Highwire
Oct 202297014Highwire
Nov 20221314136Highwire
Dec 2022614417Highwire
Jan 2023821016Highwire
Feb 20238807Highwire
Mar 2023512510Highwire
Apr 202368415Highwire
May 2023613734Highwire
Jun 2023512413Highwire
Jul 2023518010Highwire
Aug 2023926014Highwire
Sep 202331564Highwire
Oct 202331395Highwire

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. [email protected]
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Topics Discussed

Alert Me

Recommended articles